Mark your Calendars for Targeting Phage Therapy 2025

Download Brochure (JPEG | PDF)

The Scientific Committee published the first Agenda of the 8th World Conference on Targeting Phage Therapy, which will be held on June 10-11, 2025, at DoubleTree by Hilton Berlin Kudamm, Berlin, Germany.  Read More

Short Oral Deadline: May 9
Poster Deadline: May 13

Speakers Lineup 2025

Keynote Speech – Phage Therapy 2030: Getting from here to there

Robert T. Schooley

University of California, San Diego, USA

Bacteriophage Therapy: A Renaissance – From Military Medicine to Civilian Healthcare

Christian Willy

Academic Hospital Bundeswehr Berlin, Germany

KlebPhaCol: Novel Gut Phage Order Associated with the Human Gut

Franklin Nobrega

University of Southampton, United Kingdom

Phage Defense Systems: Are they an Obstacle for Phage Therapy?

Stan J.J. Brouns

Delft University of Technology, The Netherlands

Yersinia Phage Stories: Impact on Phage Therapy

Mikael Skurnik

University of Helsinki, Finland

Bacteriophages Applications in Broiler Farms: Strategies & Perspectives

Sandra Sevilla-Navarro

Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana, Spain

Phage Therapy in Europe: Legal, Regulatory and Ethic Issues

Barbara Brenner

Kanzlei BRENNER, Germany

Short Communications 2025

The Lausanne University Hospital GMP production pipeline for manufacture of therapeutic bacteriophages
Gregory Resch, Lausanne University Hospital, Switzerland

Bacteriophage-based vaccine and IL-12 Gene Therapy Eradicate Aggressive Melanoma
Andrej Cör, Valdotra Orthopaedic Hospital, Slovenia

Collateral effects of bacteriophage resistance on antibiotic sensitivity in Pseudomonas aeruginosa
Laura Rianne Baars, Leiden University, Netherland

New Insights into Bacteriophage Therapy in Dogs
Eva Maria Kalbhenn, LABOKLIN GmbH & Co. KG, Germany

Biohybrid Composites of Platelet-Rich Fibrin and Gelatin Hydrogel Beads (Nano/Micro) for Targeted Phage Delivery in the Treatment of Infected Wounds
Farzaneh Moghtader, TiPhage, Turkey

Phage-Antibiotic Composite Efficacy on Dual-Species Biofilm
Tea Glonti, Queen Astrid Military Hospital, Belgium

Anti-Quorum Sensing Phages Rescue Galleria mellonella Larvae from Pseudomonas aeruginosa Infection
Kira Céline Koonce, University of Copenhagen, Denmark

Characterization and Genomic Analysis of a New Bacteriophage Klebsiella Pneumoniae CTF-1
Kübra Can Kurt, University of Health Science, Turkey

Disruption of Biofilm by selected Bacteriophages isolated from Environmental Samples
Filip Wojnarowski, Adam Mickiewicz University Poznań, Poland

Is the Nihil a Representative of A New Genus of Bacillus Viruses?
Jakub Barylski, Adam Mickiewicz University, Poznań, Poland

Isolation and Characterization of a Novel Bacteriophage Targeting Vancomycin-Resistant Enterococcus faecium
Laura Ribes-Martínez, Fundación Jiménez Díaz, Spain

Freeze-Dried Tablets for Therapeutic Application of Bacteriophages
Marie Komárková, Masaryk University, Czech Republic

Novel Mycobacteriophages as a Promising Adjunct in the Fight Against Drug-Resistant TB and NTM Infections
Anthony Vocat, Lausanne University Hospital, Switzerland

Characterization of Escherichia Coli Bacteriophages Isolated from Wastewater in Bulgaria
Yoana Krasimirova Kizheva, Sofia University “St. Kliment Ohridski”, Bulgaria

Epizootic Situation on Salmonellosis in Private Subsidiary Farms of The Republic of Kazakhstan
Bolat Yespembetov, Research institute for biological safety problems, Kazakhstan

Аn alternative approach to Syphilis Treatment: Bacteriophage against Treponema pallidum
Nazym Syrym, Research institute for biological safety problems, Kazakhstan

Genomic diversity of Bacteriophages infecting Cronobacter spp.
Hana Drahovska, Comenius University in Bratislava, Slovak Republic

Tailored phage selection for the treatment of chronic airway infections due to MDR Pseudomonas aeruginosa
Christian van Delden, University Hospitals Geneva, Switzerland

Two novel bacteriophages vB_Bm-S567 and vB_BoMT-1/77 targeting multidrug resistant Burkholderia cepacia complex
Sopiko Sturua, G. Eliava Institute of Bacteriophages, Microbiology and Virology, Georgia

A Multifaceted Experience with Phage Therapy: A Short Review of Successful and Challenging Cases Across Multiple Body Systems
Mariam Dadiani, Eliava Phage Therapy Center, Germany

Isolation, characterization and anti-biofilm activity of lytic bacteriophage K2 against Klebsiella pneumoniae isolates
Damla Damar Celik, Marmara University, Turkey

Successful Eradication of Chronic Pseudomonas aeruginosa Infection with Personalised Bacteriophage Therapy in Children with Cystic Fibrosis: An Early Phase Clinical Trial
Jagdev Singh, The Children’s Hospital at Westmead, Australia

Analysis of the profiles of pro- and anti-inflammatory response in patients subjected to phage therapy
Hubert Oskar Kasprzak, Hirszfeld Institute of Immunology and Experimental Therapy, Poland

Rapid and specific detection of pathogenic bacteria using recombinant receptor binding proteins of bacteriophages
Peter Braun, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Germany

Addressing phage resistance: Designing effective phage cocktails against multi-drug resistant Mycobacterium abscessus
Jun Hao Liew, ASTAR Infectious Diseases Lab/ASTAR, Singapore

Monitoring bacteriophage therapy using nuclear medicine imaging
Marek Mosa, Charles University – Faculty of Science, Czechia

Who is Attending

Companies, Hospitals, Clinical Centers, and Industry Organizations

Jafral (Supporter)
Aptar Radolfzell GmbH
Centro de Calidad Avícola y Alimentación Animal de la Comunidad Valenciana

ArGe Teknoloji Sanayi ve Ticaret Anonim Şirketi
FagoFarma

TiPHAGE
Grachtenhaus-Apotheke e.K.
German Collection of Microorganisms and Cell Cultures GmbH

Kanzlei BRENNER
Komplementäre Tiermedizin GmbH

LABOKLIN GmbH & Co. KG
Laboklin Phage Center
Laboratorios Syva
MB Pharma
Medios AG
Inteliphage

Rime Bioinformatics
Phileo by Lesaffre
Phagos
Precise Health SA
Poulpharm
Salem Microbes
Academic Hospital Bundeswehr Berlin

Center de investigación en red – Enfermedades Respiratorias
Centre hospitalier universitaire vaudois
IIS-Fundación Jiménez Díaz and CIBERINFEC-Consorcio Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Infecciosas
Federal research and clinical center of intensive care medicine and rehabilitology
Hannover Medical School
Shanghai Public Health Clinical Center
Victor Babes University of Medicine and Pharmacy Timisoara
Vivantes Klinik Bavaria Kreischa

Universities and Academic Institutions

Charles University
Charité – Universitätsmedizin Berlin

Comenius University in Bratislava
Delft University of Technology
Institute of Pharmacology and Toxicology, Veterinary Medicine
INSERM

Karadeniz Technical University
Nanyang Technological University
Leibniz Institute DSMZ
Masaryk University
Max Planck Inst Molecular Genetics

Monash University
HMU Health & Medical University Erfurt

Rakuno Gakuen University
Recep Tayyip Erdoğan University
Stockholm University
Tel Aviv University
UCLouvain
Università degli Studi di Milano
University of Bologna
University of California, San Diego
Université de Paris

University of Copenhagen
University of Helsinki
University of Milan
University of Pisa
University of Roma Tor Vergata
University of Southampton
University of Warwick
Vrije Universiteit Brussel

Yale University

Practical Session: How to Produce, Manufacture, 
and Bring Phage Products to Market

Practical Phage Session

This session provides a comprehensive and hands-on approach to the entire phage product lifecycle, from laboratory preparation to industrial-scale production and market entry. Experts will address both practical challenges and administrative requirements, ensuring that participants leave with actionable insights.

Key topics include: Technical & Manufacturing Aspects, Regulatory & Administrative Aspects, Business & Market Strategy.

Read more. 

Phage Therapy 2024: Towards Personalized Phage Therapy

The 7th World Conference on Targeting Phage Therapy 2024 on June 20-21 at Corinthia Palace in Malta was a great success. Over 40 presentations on the latest phage research were delivered to an audience of over 100 attendees representing 35 countries. Read more.

Captured Moments.